Display options
Share it on

Arch Bone Jt Surg. 2014 Jun;2(2):106-10. Epub 2014 Jun 15.

Prevalence of malignant soft tissue tumors in extremities: an epidemiological study in syria.

The archives of bone and joint surgery

Habib Reshadi, Alireza Rouhani, Saeid Mohajerzadeh, Marvan Moosa, Asghar Elmi

Affiliations

  1. Habib Reshadi MD, Alireza Rouhani MD, Saeid Mohajerzadeh MD, Orthopedic Department, Shohada Hospital, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.

PMID: 25207328 PMCID: PMC4151447

Abstract

BACKGROUND: Although the majority of soft tissue masses are benign, it is important to consider malignancy in differential diagnoses. Because most soft tissue sarcomas present as a painless mass, clinicians must watch for signs suggestive of malignancy, including large size, rapid growth, and site deep into the deep fascia. The purpose of this study was to determine the relative prevalence according to sex and age, site of tumor, skeletal distribution, and treatment (surgery, chemotherapy and radiotherapy) before and after surgery, and ascertain the relative frequency of these tumors in specific anatomic sites and age groups based on pathological studies.

METHODS: A total of 308 patients, with a musculoskeletal tumor were evaluated retrospectively. All of the patients enrolled into this study were referred to the Beirouni Hospital of Damascus University with a proven diagnosis of malignant soft tissue tumors from the beginning of January 2008 until the end of 2010. The prevalence of the malignant soft tissue tumors in these patients was analyzed. For purposes of analysis, all lesions were placed in 1 of 9 categories: hand and wrist, forearm, humorous (arm), proximal limb girdle (axilla and shoulder), foot and ankle, thigh, hip and buttocks region, trunk, and other lesions. Age and sex also were recorded.

RESULTS: MALIGNANT TUMORS CONSISTED OF SEVEN DIAGNOSTIC CATEGORIES: malignant fibrous histiocytoma (23%), liposarcoma (22%), rhabdomyosarcoma (9%), leiomyosarcoma (8%), malignant schwannoma (5%), dermatofibrosarcoma protuberans (5%), synovial sarcoma (10%), fibrosarcoma (13%), extraskeletal chondrosarcoma (1%), and extraskeletal Ewing sarcoma (4%).

CONCLUSIONS: Despite the multitude of pathologic possibilities, most malignant soft-tissue tumors are classified into a small number of diagnoses. These may be further defined when the site of the lesion and the age of the patient are considered. Knowledge of tumor prevalence will assist radiologists in establishing a suitably ordered differential diagnosis when a soft-tissue tumor has a nonspecific radiologic appearance.

Keywords: Oncology; Sarcoma; Syria

References

  1. Acta Orthop Scand Suppl. 1994 Jun;259:1-31 - PubMed
  2. Cancer. 1993 Jul 15;72(2):486-90 - PubMed
  3. AJR Am J Roentgenol. 1995 Jan;164(1):129-34 - PubMed
  4. Semin Oncol. 1997 Oct;24(5):504-14 - PubMed
  5. Int J Cancer. 2006 Dec 15;119(12):2922-30 - PubMed
  6. Eur J Cancer. 1999 Nov;35(12):1711-6 - PubMed
  7. Am Fam Physician. 1999 Aug;60(2):567-72 - PubMed
  8. J Bone Joint Surg Am. 1996 May;78(5):650-5 - PubMed
  9. Ann Surg. 1982 Sep;196(3):305-15 - PubMed
  10. Ann Oncol. 2010 May;21(5):1106-11 - PubMed
  11. Cancer Surv. 1994;19-20:197-217 - PubMed

Publication Types